(Q46025722)

English

The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study).

scientific article published in September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study). (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

Markus Büchler

2

object named as

M Büchler

1 reference

Europe PubMed Central

18 December 2017

author name string

R Abou-Ayache

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

P Le Pogamp

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

P-F Westeel

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

Y Le Meur

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

I Etienne

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

B Hurault de Ligny

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

O Toupance

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

S Caillard

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

G Sinnasse-Raymond

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

G Touchard

11

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

language of work or name

0 references

publication date

1 September 2011

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

Transplantation Proceedings

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

43

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

2630-2635

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Long-term results of rabbit antithymocyte globulin and basiliximab induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Benefits of cytomegalovirus prophylaxis in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Prevention of cytomegalovirus disease in renal transplantation: single-center experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.05.050

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2011.05.050

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/21911136

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46025722&oldid=1629781496"